Two MD Anderson faculty named as prestigious AAAS Fellows
MD Anderson News Release 11/23/2015
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough...
MD Anderson receives $22.2 million in CPRIT research funding
MD Anderson News Release 11/20/2015
The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research...
Tumor-suppressor p53 regulates protein that stifles immune...
Research makes microRNA case for blocking PDL1; related drug in phase I clinical trials
MD Anderson News Release 11/20/2015
<...
ARCH Venture Partners, Flagship Ventures and MD Anderson...
Company secures $80-plus million in committed funding to develop exosome-based therapeutic and diagnostic products
MD Anderson News...
Research points to why some colorectal cancers recur after...
MD Anderson study sheds new light on monoclonal antibody therapy cetuximab
MD Anderson News Release 11/16/2015
Cetuximab...
New York businessman, philanthropist gives $30 million to...
Andrew Sabin Fellowship Program aims to advance MD Anderson’s goal to end cancer
MD Anderson News Release 11/16/2015
Study reveals why chemotherapy may be compromised in...
MD Anderson News Release 11/11/2015
A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy...
Dallas A Conversation With a Living Legend® to honor Dr....
Journalist Norah O’Donnell will interview Rice at dinner benefiting cancer research
MD Anderson News Release 11/09/2015
...
Increased meat consumption, especially when cooked at high...
MD Anderson study also finds individuals with certain genetic variations more vulnerable to dietary risk
MD Anderson News Release...
CytomX and MD Anderson Cancer Center Enter Into Strategic...
Collaboration Combines Leading Research in Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell Therapies with CytomX’s Probody...